Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Rational development of a novel TFPI-like inhibitor from Amblyomma cajennense tick

Full text
Author(s):
Morais, Katia L. P. [1] ; Mesquita Pasqualoto, Kerly Fernanda [1] ; Fernandes Pacheco, Mario Thiego [1] ; Berra, Carolina Maria [1] ; Alvarez-Flores, Miryam Paola [1] ; Chudzinski-Tavassi, Ana Marisa [1]
Total Authors: 6
Affiliation:
[1] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo - Brazil
Total Affiliations: 1
Document type: Review article
Source: Toxin Reviews; v. 33, n. 1-2, SI, p. 48-52, MAR-JUN 2014.
Web of Science Citations: 3
Abstract

Hematophagous organisms have been described to possess specific blood coagulation inhibitors with different structures and novel mechanism of action. A factor Xa inhibitor was identified through the salivary glands transcriptome from the adult Amblyomma cajennense tick. The recombinant form was expressed in Escherichia coli and named Amblyomin-X. The recombinant protein not only inhibits factor X, but is also able to inhibit the activation of factor X by the extrinsic tenase complex. It seems to activate the apoptosis pathway through proteasome inhibition and endoplasmic reticulum-stress. It promotes regression and reduction of lung metastasis in murine melanoma tumor, and does not affect normal cells, emphasizing its selectivity of action. (AU)

FAPESP's process: 11/05969-4 - Investigating the role of dynein in the mechanism of antitumor action of Amblyomin-X in melanoma cells and pancreatic adenocarcinoma
Grantee:Mario Thiego Fernandes Pacheco
Support type: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 10/07958-7 - EVALUATION OF THE PRO-APOPTOTIC MECHANISM OF ACTION OF THE AMBLYOMIN-X
Grantee:Kátia Luciano Pereira Morais
Support type: Scholarships in Brazil - Doctorate